Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest update is out from ADMA Biologics ( (ADMA) ).
ADMA Biologics, Inc. has reassured analysts that the recent change in auditors, detailed in their latest report, will not affect the financial projections for the years 2024-2025. The company’s management confirmed that the transition of auditors is expected to proceed without impacting their previously stated financial guidance.
See more data about ADMA stock on TipRanks’ Stock Analysis page.
